# NorthStar and IBA expand collaboration for Tc-99m availability

NorthStar Medical Radioisotopes and IBA expanded their collaboration to enable global availability of technetium-99m (Tc-99m) using NorthStar's non-uranium based Mo-99 produced with IBA accelerators. The expansion builds on an existing contract for up to eight Rhodotron accelerators.

- Type: Partnership
- Announced: 2021-03-08
- Where: Beloit, Wisconsin, United States
- Status: announced
- Products: technetium-99m generators, Rhodotron electron beam accelerators
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [IBA S.A.](https://endata.com/companies/44009.md) (partner)
- [NorthStar Medical Radioisotopes](https://endata.com/companies/53696.md) (partner)

## Sources

- [biospace.com](https://www.biospace.com/northstar-medical-radioisotopes-and-iba-expand-collaboration-to-enable-global-availability-of-diagnostic-radioisotope-technetium-99m-tc-99m), 2021-03-08: "The collaboration enables companies outside of the United States to access the Tc-99m Generation Systems that utilize NorthStar's proprietary non-uranium based Mo-99 produced using IBA's accelerators and beamlines."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.